Sachetta »

Keros Therapeutics shares owned by Sachetta

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Sachetta from 13F filings

Historical chart of Sachetta investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Sachetta consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Sachetta

Quarter filed Position value Share count Share price at filing
2024-03-31 $19k 488 39.76
2023-12-31 $19k 488 39.76

More positions owned by Sachetta

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Rus 1000 Etf (IWB)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Ishares Tr North Amern Nat (IGE)
Ishares Tr U.s. Bas Mtl Etf (IYM)
Ishares Tr Rus Mid Cap Etf (IWR)
Ishares Tr Core S&p Scp Etf (IJR)
Microsoft Corporation (MSFT)
Wisdomtree Tr Itl Hdg Qtly Div (IHDG)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Ishares Tr Mbs Etf (MBB)
Spdr Ser Tr S&p Divid Etf (SDY)
Ishares Tr Core S&p500 Etf (IVV)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)

View all positions for Sachetta

Top funds holding Keros Therapeutics

FMR
BlackRock
Vanguard Group
Darwin Global Management
OrbiMed Advisors
T. Rowe Price Associates
Point72 Asset Management
Woodline Partners
Braidwell
Eventide Asset Management
Candriam Luxembourg S.C.A.
Holocene Advisors
Leucadia National Corporation
Franklin Resources
Geode Capital Management

View all funds holding Keros Therapeutics